CARD11 Gene B-cell expansion with NFKB and T-cell anergy Genetic Test
At DNA Labs UAE, we offer the CARD11 Gene B-cell expansion with NFKB and T-cell anergy Genetic Test for diagnosing and managing immune disorders. This test is specifically designed to identify mutations in the CARD11 gene, which is responsible for regulating the immune system.
Test Details
The CARD11 gene encodes for a protein involved in immune system regulation. Mutations in this gene have been associated with various immune disorders, including B-cell expansion with NFKB and T-cell anergy. B-cell expansion with NFKB and T-cell anergy is a rare immune disorder characterized by abnormal expansion of B-cells and impaired T-cell function. It is caused by mutations in the CARD11 gene, which leads to dysregulation of the NF-kappaB signaling pathway.
Our genetic test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of B-cell expansion with NFKB and T-cell anergy, NGS genetic testing can be used to identify mutations in the CARD11 gene, confirming the diagnosis of the condition.
By identifying the specific mutation in the CARD11 gene, our NGS genetic testing can also provide important information for personalized treatment strategies. Targeted therapies can be developed to specifically address the underlying genetic defect and potentially improve the clinical outcomes for individuals with B-cell expansion with NFKB and T-cell anergy.
Test Components and Price
Our CARD11 Gene B-cell expansion with NFKB and T-cell anergy Genetic Test is priced at AED 4400.0. The test requires a blood sample or extracted DNA, or just one drop of blood on an FTA card. The report delivery time is estimated to be 3 to 4 weeks.
Test Department and Doctor
The CARD11 Gene B-cell expansion with NFKB and T-cell anergy Genetic Test is conducted by our Genetics department. The test is recommended by Dermatologists for patients with clinical symptoms related to immune system disorders.
Pre Test Information
Prior to undergoing the CARD11 Gene B-cell expansion with NFKB and T-cell anergy Genetic Test, it is important to provide a clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by CARD11 Gene B-cell expansion with NFKB and T-cell anergy.
By offering NGS genetic testing for the CARD11 gene, DNA Labs UAE aims to provide a valuable tool for diagnosing and managing B-cell expansion with NFKB and T-cell anergy. This test allows for personalized treatment approaches based on the individual’s genetic profile, leading to improved clinical outcomes.
| Test Name | CARD11 Gene B-cell expansion with NFKB and T-cell anergy Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CARD11 Gene B-cell expansion with NFKB and T-cell anergy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CARD11 Gene B-cell expansion with NFKB and T-cell anergy NGS Genetic DNA Test gene CARD11 |
| Test Details |
The CARD11 gene is a gene that encodes for a protein involved in immune system regulation. Mutations in this gene have been associated with various immune disorders, including B-cell expansion with NFKB and T-cell anergy. B-cell expansion with NFKB and T-cell anergy is a rare immune disorder characterized by abnormal expansion of B-cells and impaired T-cell function. This condition is caused by mutations in the CARD11 gene, which leads to dysregulation of the NF-kappaB signaling pathway. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of B-cell expansion with NFKB and T-cell anergy, NGS genetic testing can be used to identify mutations in the CARD11 gene, which confirms the diagnosis of the condition. By identifying the specific mutation in the CARD11 gene, NGS genetic testing can also provide important information for personalized treatment strategies. Targeted therapies can be developed to specifically address the underlying genetic defect and potentially improve the clinical outcomes for individuals with B-cell expansion with NFKB and T-cell anergy. Overall, NGS genetic testing for the CARD11 gene is a valuable tool for diagnosing and managing B-cell expansion with NFKB and T-cell anergy, allowing for personalized treatment approaches based on the individual’s genetic profile. |
